Carroll Financial Associates’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-85
Closed -$1K 1297
2018
Q2
$1K Hold
85
﹤0.01% 1187
2018
Q1
$2K Hold
85
﹤0.01% 1138
2017
Q4
$2K Hold
85
﹤0.01% 1117
2017
Q3
$2K Hold
85
﹤0.01% 1092
2017
Q2
$1K Hold
85
﹤0.01% 1125
2017
Q1
$1K Hold
85
﹤0.01% 1118
2016
Q4
$1K Hold
85
﹤0.01% 1078
2016
Q3
$1K Sell
85
-1
-1% -$12 ﹤0.01% 1094
2016
Q2
$0 Hold
86
﹤0.01% 1125
2016
Q1
$0 Hold
86
﹤0.01% 1116
2015
Q4
$0 Hold
86
﹤0.01% 1085
2015
Q3
$0 Hold
86
﹤0.01% 1064
2015
Q2
$1K Hold
86
﹤0.01% 1009
2015
Q1
$1K Hold
86
﹤0.01% 761
2014
Q4
$1K Hold
86
﹤0.01% 688
2014
Q3
$0 Hold
86
﹤0.01% 823
2014
Q2
$1K Hold
86
﹤0.01% 848
2014
Q1
$1K Hold
86
﹤0.01% 800
2013
Q4
$0 Hold
86
﹤0.01% 795
2013
Q3
$0 Hold
86
﹤0.01% 791
2013
Q2
$0 Buy
+86
New +$499 ﹤0.01% 614

Other funds holding ACLS

Carroll Financial Associates's ACLS Position: Q3 2018 in Review

Carroll Financial Associates sold out of Axcelis (ACLS) in Q3 2018, closing a stake of 85 shares — an estimated $1K sold.

Carroll Financial Associates first reported a position in ACLS in Q2 2013 and held it in 21 quarters. The position peaked at $2K in Q1 2018. 154 funds tracked by Wall St. Rank hold ACLS as of Q3 2018.

  • Carroll Financial Associates reported no remaining Axcelis position as of Q3 2018 after selling out during the quarter.
  • Carroll Financial Associates sold 85 Axcelis shares in Q3 2018, an estimated $1K.
  • Carroll Financial Associates first reported a position in Axcelis in Q2 2013 and held it in 21 quarters.
  • Carroll Financial Associates's Axcelis position peaked at $2K in Q1 2018.
  • 154 funds tracked by Wall St. Rank held Axcelis as of Q3 2018.

Based on Carroll Financial Associates's 13F filing for Q3 2018, filed 30 Oct 2018.